Switzerland · Delayed Price · Currency is CHF SIG Group AG Earnings Call Transcripts
Fiscal Year 2026
-
Revenue was stable at constant currency, with improved profitability and cash flow despite FX headwinds. Aseptic carton growth in Asia and EMEA offset declines in Europe and Americas, while restructuring and cost actions supported margins. Full-year guidance is maintained.
Fiscal Year 2025
-
Sequential improvement in Q4 led to modest full-year growth, with strong performance in the Americas and continued innovation. EUR 351 million in non-recurring charges impacted results, but guidance for 2026 anticipates stable to modest growth and margin improvement.
-
Leadership is driving an operational reset with a focus on aseptic technology, innovation, and disciplined capital allocation. Guidance targets 0-2% organic growth in 2026, 3-5% mid-term, margin expansion, and improved cash flow, with sustainability and portfolio optimization as key pillars.
-
Q3 saw revenue and EBITDA decline due to weak consumer sentiment and inventory destocking, with €320 million in non-recurring charges mainly for asset impairments. Guidance for 2025 is flat to slightly negative revenue growth, with a pause in the dividend and a focus on capital discipline.
-
Revenue grew 2.1% in H1 2025 despite subdued markets, with strong innovation and share gains. Adjusted EBITDA margin reached 23.6%, but FX headwinds and higher customer incentives weighed on free cash flow. FY guidance narrowed to lower end of 3%-5% revenue growth and 24.5%-25.5% EBITDA margin.
-
Q1 2025 saw 3.2% revenue growth at constant currency and resin, with adjusted EBITDA margin up to 22.3%. Guidance for 3%-5% annual growth and 24.5%-25.5% EBITDA margin is maintained, with H2 expected to be stronger due to new filler installations and operational efficiencies.
Fiscal Year 2024
-
2024 saw 6% revenue growth and strong market share gains, with robust innovation and sustainability achievements. Free cash flow rose 30% and net leverage improved, while guidance for 2025 targets 3%-5% revenue growth and stable margins. Legal and market uncertainties persist.
-
Q3 2024 saw solid revenue and EBITDA growth, with strong performance in Europe, EMEA, and improving trends in the Americas. Operational bottlenecks in North America eased, free cash flow and leverage improved, and full-year guidance was confirmed, with volume as the main growth driver.
-
Carton segments outperformed with strong growth, while bag-in-box and spouted pouch lagged due to North American demand softness and operational issues. Guidance was revised lower for EBITDA margin, but revenue growth is expected to improve, supported by ongoing remediation and strong filler placements.